These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 7229835)
1. Preparation and use of drug master files in the pharmaceutical industry. Personeus GR; Ascione P J Parenter Sci Technol; 1981; 35(2):63-9. PubMed ID: 7229835 [No Abstract] [Full Text] [Related]
2. New drug applications; drug master files. Food and Drug Administration, HHS. Final rule. Fed Regist; 2000 Jan; 65(8):1776-80. PubMed ID: 11010656 [TBL] [Abstract][Full Text] [Related]
3. International research agreement leads to new U.S. guidelines. Maloney DM Hum Res Rep; 1995 Apr; 10(4):1-2. PubMed ID: 11654182 [No Abstract] [Full Text] [Related]
4. Drug safety: the viewpoint of the pharmaceutical manufacturing industry. Wigle WW Can Med Assoc J; 1968 Feb; 98(6):314-7. PubMed ID: 5636099 [No Abstract] [Full Text] [Related]
5. Progress under the Kefauver-Harris Drug Amendments. Rankin WB Pharmakotherapia; 1964; 2(1):215-22. PubMed ID: 5875717 [No Abstract] [Full Text] [Related]
6. Pharmaceutical GMPs. Bobrowicz G Qual Assur; 1994 Jun; 3(2):138-48. PubMed ID: 7804629 [No Abstract] [Full Text] [Related]
7. Biopharmaceutic equivalency and the role of the Food & Drug Administration. Hodges RM Am J Hosp Pharm; 1968 Mar; 25(3):121-7. PubMed ID: 5658859 [No Abstract] [Full Text] [Related]
8. Drug discovery. Kennedy D Science; 2004 Mar; 303(5665):1729. PubMed ID: 15031461 [No Abstract] [Full Text] [Related]
9. Assessments of pharmaceutical advertisements: a critical analysis of the criticism. Beales JH; MacLeod WC Food Drug Law J; 1995; 50(3):415-49. PubMed ID: 10343010 [No Abstract] [Full Text] [Related]
10. DTC drug ads in the spotlight. Guglielmo WJ Med Econ; 2006 Sep; 83(18):20. PubMed ID: 17037630 [No Abstract] [Full Text] [Related]
12. The relationship between the pharmaceutical industry and government agencies. Johnston RV J Am Vet Med Assoc; 1965 Dec; 147(12):1588-92. PubMed ID: 5884057 [No Abstract] [Full Text] [Related]
13. The drug recall dilemma. Provost GP Am J Hosp Pharm; 1966 Oct; 23(10):541. PubMed ID: 5915775 [No Abstract] [Full Text] [Related]
14. Issues in bringing new drugs to the market. Tracey WR Science; 2005 Dec; 310(5753):1425-6; author reply 1425-6. PubMed ID: 16329172 [No Abstract] [Full Text] [Related]
15. Pharmaceutical industry restructuring and new marketing approaches: enforcement responses. Mahinka SP; Sanzo KM Food Drug Law J; 1995; 50(2):313-25. PubMed ID: 10343000 [No Abstract] [Full Text] [Related]
16. Prescription drug advertising--should states regulate what is false and misleading? Shaeffer J Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454 [No Abstract] [Full Text] [Related]
17. Problems relating to investigational drugs. Kelsey O Pharmakotherapia; 1964; 2(1):208-12. PubMed ID: 5875715 [No Abstract] [Full Text] [Related]
18. Clinical quality assurance in the pharmaceutical industry. Donahue JJ Cancer Treat Rep; 1985 Oct; 69(10):1195-7. PubMed ID: 4042098 [No Abstract] [Full Text] [Related]
19. New York State and drug lists: a history of confusion. Stetler CJ Med Mark Media; 1978 Sep; 13(9):36, 38, 40 passim. PubMed ID: 10316687 [No Abstract] [Full Text] [Related]
20. The evolution of new drug legislation. Kelsey FO BMQ; 1966 Sep; 17(3):72-81. PubMed ID: 5978212 [No Abstract] [Full Text] [Related] [Next] [New Search]